Viral Safety for Biologicals

Hotel Pullman Cologne Helenenstraße 14, Köln, Germany

The 7th Annual Viral Safety for Biologicals conference will take place June 24-25, 2014 in Cologne, Germany. Join over 60+ viral safety experts from recombinant, vaccines and plasma industries to discuss the latest in research and requirements, including case studies and introductions to new technologies. Please visit Informa Life Science’s Viral Safety for Biologicals website

NACCHO Annual 2014

Hilton Atlanta 255 Courtland Street NE, Atlanta, GA, United States

NACCHO Annual 2014, the annual conference of the National Association of County and City Health Officials, will be held July 8-10, 2014 in Atlanta, Georgia. This year’s theme is “The New Era of Public Health”. NACCHO Annual 2014 is an opportunity to join a thousand of your colleagues for the year’s largest gathering of local

ImVacS 2014

Marriott Long Wharf Hotel 296 State St, Boston, MA, United States

The 9th Annual ImVacS 2014 Immunotherapies and Vaccine Summit will be held August 11-14, 2014 in Boston, Massachusetts. ImVacS 2014 brings together a global audience of vaccine researchers and developers of cancer immunotherapies for five focused meetings that explore the frontiers of immunology as the basis for patient treatment. 250+ researchers from around the world

World Vaccine Congress 2016

Grand Hyatt Washington 1000 H St NW, Washington DC, United States

The World Vaccine Congress US 2016 will be held March 29-31, 2016 in Washington, DC. The event draws more than 150 elite speakers and 500 attendees from across big pharma, biotech, academics and government organizations. 7 different conference streams are available, including for Emerging & Re-Emerging Diseases; Influenza & Respiratory; and Clinical Trials conference tracks.

Preventing & Treating Biological Exposures

Eagleson Institute 161 Gate House Road, Sanford, ME, United States

The Eagleson Institute, in partnership with the Elizabeth R. Griffin Research Foundation, will host Preventing & Treating Biological Exposures – An Occupational Health Colloquium on June 13-15, 2016 in Austin, Texas. This annual gathering brings together all those who help safeguard the health of biological laboratory workers in a highly interactive format that encourages sharing

BARDA Industry Day 2016

Ronald Reagan Building 1300 Pennsylvania Ave NW, Washington D.C., United States

The Biomedical Advanced Research and Development Authority’ BARDA Industry Day (BID) 2016 will take place from October 18-20, 2016 in Washington, DC. The event offers participants opportunities to learn about U.S. Government medical countermeasure requirements, interact with BARDA staff, and network with private sector colleagues working in this space. BARDA supports the advanced research & development, manufacturing, acquisition,

Superbugs & Superdrugs USA

Renaissance Woodbridge Hotel 515 US-1, Iselin, NJ, United States

SMi Group will host this year's Superbugs and Superdrugs USA on November 13-14, 2017 in Iselin, New Jersey. Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect

8th FIDSSA Congress – Federation of Infectious Diseases Societies of Southern Africa

Indaba Hotel, Spa and Conference Centre William Nicol Dr &, Pieter Wenning Rd, Fourways, South Africa

The 8th Federation of Infectious Diseases Societies of Southern Africa FIDSSA Congress 2019 will be held at the Indaba Hotel and Conference Centre, Johannesburg, South Africa from 7-9 November 2019. This biennial FIDSSA Congress attracts local and international experts to lead conversations on a wide spectrum of cutting-edge infectious diseases topics relevant to the region

VRBPAC Meeting on Janssen and Moderna COVID-19 Vaccine Boosters

Virtual Event Virtual Event

On Oct. 14 and 15, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet to discuss the use of booster doses of the Moderna COVID-19 Vaccine and the Janssen COVID-19 Vaccine. Both vaccines are currently authorized for emergency use to prevent COVID-19 in individuals 18 years of age and older. The committee